SCHEMBL22221986

SCHEMBL22221986

c1ccc2sc(-c3ccc4oc(-c5ccc6cn[nH]c6c5)nc4c3)cc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 3/20 0.43
KDM4E B2RXH2 6/20 0.39
ALDH1A1 P00352 6/20 0.39
NPC1 O15118 5/20 0.39
RAB9A P51151 5/20 0.39
SMN1; SMN2 Q16637 5/20 0.39
HPGD P15428 5/20 0.39
TP53 P04637 3/20 0.39
MAPT P10636 4/20 0.38
NFKB1 P19838 2/20 0.38
STAT1 P42224 2/20 0.38
NFKB2 Q00653 2/20 0.38
RELA Q04206 2/20 0.38
GFER P55789 2/20 0.38
GAA P10253 2/20 0.38
HCRTR1 O43613 1/20 0.38
LMNA P02545 1/20 0.38
UTRN P46939 5/20 0.38
CYP1A2 P05177 1/20 0.38
AHR P35869 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19492650 0.92 FGFR1 (0.43) FGFR1KDM4EALDH1A1NPC1RAB9A
SCHEMBL10269114 0.85 FGFR1 (0.58) FGFR1KDM4EMAPTAPPFGFR2
SCHEMBL20759159 0.83 GSK3B (0.43) FGFR1KDM4EALDH1A1NPC1RAB9A
SCHEMBL19300563 0.77 ALDH1A1 (0.46) FGFR1KDM4EALDH1A1NPC1RAB9A
SCHEMBL22100552 0.76 FGFR1 (0.45) FGFR1NPC1RAB9AMAPTROCK2
SCHEMBL13201333 0.75 GSK3B (0.58) FGFR1APPROCK2ROCK1MAPKAPK2
SCHEMBL19006165 0.74 ALDH1A1 (0.57) FGFR1KDM4EALDH1A1NPC1RAB9A
SCHEMBL5835501 0.74 NPC1 (0.50) KDM4EALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL21264276 0.73 APP (0.47) FGFR1KDM4EALDH1A1NPC1RAB9A
SCHEMBL19772292 0.71 NPC1 (0.44) KDM4EALDH1A1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11839679-B2 Gamma-diketones for treatment and prevention of aging skin and wrinkles BIOSPLICE THERAPEUTICS, INC. (US) 2023-12-12 US disclosed
US-20220087917-A1 GAMMA-DIKETONES FOR TREATMENT AND PREVENTION OF AGING SKIN AND WRINKLES VICKERS VENTURE FUND VI PTE. LTD. (SG) 2022-03-24 US disclosed
US-11077046-B2 Gamma-diketones for treatment and prevention of aging skin and wrinkles BIOSPLICE THERAPEUTICS, INC. (US) 2021-08-03 US disclosed
US-20200222295-A1 GAMMA-DIKETONES FOR TREATMENT AND PREVENTION OF AGING SKIN AND WRINKLES MED-PATHWAYS II LIMITED (VG) 2020-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11077046-B2 Gamma-diketones for treatment and prevention of aging skin and wrinkles GLA, DGKG, DGKA FGFR1 1082/4885KDM4E 656/4885ALDH1A1 985/4885
US-20220087917-A1 GAMMA-DIKETONES FOR TREATMENT AND PREVENTION OF AGING SKIN AND WRINKLES GLA, DGKG, DGKA FGFR1 1082/4885KDM4E 656/4885ALDH1A1 985/4885
US-20200222295-A1 GAMMA-DIKETONES FOR TREATMENT AND PREVENTION OF AGING SKIN AND WRINKLES GLA, DGKG, DGKA FGFR1 1082/4885KDM4E 656/4885ALDH1A1 985/4885
US-11839679-B2 Gamma-diketones for treatment and prevention of aging skin and wrinkles DGKG, DGKA, DNER FGFR1 1593/4885KDM4E 417/4885ALDH1A1 1485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.